(1.10%) 5 103.81 points
(0.48%) 38 268 points
(1.92%) 15 912 points
(0.41%) $83.91
(-3.42%) $1.582
(0.52%) $2 354.60
(0.68%) $27.54
(0.40%) $924.20
(0.30%) $0.934
(0.70%) $11.03
(0.14%) $0.800
(-0.24%) $91.95
Live Chart Being Loaded With Signals
Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. The company's Fine Chemical division manufactures and sells active pharmaceutical ingredients and medical supplies for antipyretic, analgesic, anti-inflammatory, and vasoconstrictor areas...
Stats | |
---|---|
Today's Volume | 60 500.00 |
Average Volume | 70 677.00 |
Market Cap | 19.32B |
EPS | ¥0 ( 2024-04-12 ) |
Next earnings date | ( ¥0 ) 2024-07-10 |
Last Dividend | ¥9.00 ( 2023-05-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 11.89 |
ATR14 | ¥0.603 (0.12%) |
Volume Correlation
Astena Holdings Co., Ltd. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Astena Holdings Co., Ltd. Correlation - Currency/Commodity
Astena Holdings Co., Ltd. Financials
Annual | 2023 |
Revenue: | ¥51.98B |
Gross Profit: | ¥15.17B (29.19 %) |
EPS: | ¥29.47 |
FY | 2023 |
Revenue: | ¥51.98B |
Gross Profit: | ¥15.17B (29.19 %) |
EPS: | ¥29.47 |
FY | 2022 |
Revenue: | ¥49.64B |
Gross Profit: | ¥15.44B (31.11 %) |
EPS: | ¥14.56 |
FY | 2021 |
Revenue: | ¥72.32B |
Gross Profit: | ¥16.60B (22.96 %) |
EPS: | ¥46.86 |
Financial Reports:
No articles found.
Astena Holdings Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥9.00 (N/A) |
¥0 (N/A) |
¥9.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥2.75 | 2001-05-28 |
Last Dividend | ¥9.00 | 2023-05-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 38 | -- |
Total Paid Out | ¥149.50 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.32 | -- |
Div. Sustainability Score | 9.60 | |
Div.Growth Potential Score | 3.35 | |
Div. Directional Score | 6.47 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8359.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7735.T | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
6918.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6278.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
4994.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4203.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3402.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
2491.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
9418.T | Ex Dividend Knight | 2023-08-30 | Annually | 0 | 0.00% | |
8081.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0306 | 1.500 | 9.39 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0245 | 1.200 | 9.18 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0583 | 1.500 | -0.463 | -0.695 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.262 | 0.800 | 8.69 | 6.95 | [1 - 3] |
quickRatioTTM | 0.843 | 0.800 | 9.75 | 7.80 | [0.8 - 2.5] |
cashRatioTTM | 0.162 | 1.500 | -0.210 | -0.315 | [0.2 - 2] |
debtRatioTTM | 0.236 | -1.500 | 6.06 | -9.09 | [0 - 0.6] |
interestCoverageTTM | 22.43 | 1.000 | 2.81 | 2.81 | [3 - 30] |
operatingCashFlowPerShareTTM | 89.20 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 89.20 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.546 | -1.500 | 7.81 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.323 | 1.000 | 7.95 | 7.95 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0318 | 1.000 | -1.364 | -1.364 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.226 | 1.000 | 9.86 | 9.86 | [0.2 - 2] |
assetTurnoverTTM | 0.798 | 0.800 | 8.01 | 6.41 | [0.5 - 2] |
Total Score | 9.60 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 11.91 | 1.000 | 8.90 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0583 | 2.50 | -0.298 | -0.695 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 89.20 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.70 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 89.20 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.116 | 1.500 | -2.56 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0669 | 1.000 | -0.826 | 0 | [0.1 - 0.5] |
Total Score | 3.35 |
Astena Holdings Co., Ltd.
Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. The company's Fine Chemical division manufactures and sells active pharmaceutical ingredients and medical supplies for antipyretic, analgesic, anti-inflammatory, and vasoconstrictor areas. Its Medical division is involved in the biotechnology related business, such as the provision of drug development support services; and sale of medical equipment. The company's Health & Beauty Care, and Food division engages in the sale of over-the-counter drugs, food product materials, functional food product materials, and cosmetic ingredients; mail/Internet-ordered sales business; and OEM production of cosmetics. Its Industrial Chemicals division manufactures and sells surface finishing chemicals and other chemical products, such as products for PWBs, electronic devices, general platings, and semiconductors. The company was formerly known as Iwaki & Co., Ltd. and changed its name to Astena Holdings Co.,Ltd. in June 2021. Astena Holdings Co., Ltd. was founded in 1914 and is based in Chuo, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators